2025

Subcutaneous foslevodopa/foscarbidopa initiation in a Parkinson's day-clinic - a suitable setting to ensure treatment efficacy, tolerability and psychosocial adaption
Jander A, Bergner S, Schönwald B, Pötter-Nerger M, Buhmann C, Hidding U
FRONT AGING NEUROSCI. 2025;17:.

2022

Interleukin-1 Mediates Ischemic Brain Injury via Induction of IL-17A in γδ T Cells and CXCL1 in Astrocytes
Schädlich I, Vienhues J, Jander A, Piepke M, Magnus T, Lambertsen K, Clausen B, Gelderblom M
NEUROMOL MED. 2022;24(4):437-451.

2021

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response
Piepke M, Clausen B, Ludewig P, Vienhues J, Bedke T, Javidi E, Rissiek B, Jank L, Brockmann L, Sandrock I, Degenhardt K, Jander A, Roth V, Schädlich I, Prinz I, Flavell R, Kobayashi Y, Renné T, Gerloff C, Huber S, Magnus T, Gelderblom M
J NEUROINFLAMM. 2021;18(1):.

Letzte Aktualisierung aus dem FIS: 25.11.2025 - 05:25 Uhr